NASDAQ: INDV - Indivior PLC

Rentabilität für sechs Monate: -18.93%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Indivior PLC

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd.

weitere details
The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2014-12-29
ISIN GB00BN4HT335
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 12.24
Дивиденд ао 0.475
Сайт https://www.indivior.com
Цена ао 8.71
Preisänderung pro Tag: +0.487% (12.32)
Preisänderung pro Woche: +6.17% (11.66)
Preisänderung pro Monat: +9.27% (11.33)
Preisänderung über 3 Monate: +23.31% (10.04)
Preisänderung über sechs Monate: -18.93% (15.27)
Preisänderung pro Jahr: -18.93% (15.27)
Preisänderung über 3 Jahre: +1 792.97% (0.654)
Preisänderung über 5 Jahre: +12 959.07% (0.0948)
Preisänderung über 10 Jahre: 0% (12.38)
Preisänderung seit Jahresbeginn: +17.01% (10.58)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 1.91 7
P/BV 58.87 1
P/E 1067.05 1
EV/EBITDA 7.17 9
Gesamt: 5.88

Effizienz

Name Bedeutung Grad
ROA, % 0.1025 1
ROE, % 2.95 1
Gesamt: 3.5

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0.6667 6.67
Gesamt: 4.22

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0.8467 9
Gesamt: 7.8

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 39.24 5
Rentabilität Ebitda, % -70.17 0
Rentabilität EPS, % -98.46 0
Gesamt: 1
Weitere Details

Institutionen Volumen Aktie, %
Two Seas Capital LP 13670312 9.96
Scopia Capital Management LP 8311367 6.06
Vanguard Group Inc 5846354 4.26
Goldman Sachs Group Inc 5683038 4.14
FMR, LLC 5498087 4.01
Artemis Investment Management LLP 3127399 2.28
Bank of America Corporation 2701855 1.97
Polar Capital Holdings PLC 2621150 1.91
Acadian Asset Management. LLC 2281179 1.66
Liontrust Investment Partners LLP 1995889 1.45

ETF Aktie, % Rentabilität für das Jahr, % Dividenden, %
Schwab International Small-Cap Equity ETF 0.05297 10.07 3.20638
Vanguard FTSE All-World ex-US Small-Cap ETF 0.05 9.39 3.09932
Dimensional International Small Cap ETF 0.03912 5.69 3.34747
Avantis International Small Cap Value ETF 0.03727 14.36 4.23496
Avantis International Equity ETF 0.01813 6.46 3.80856
Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.01806 2.77 3.5165
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund 0.01219 5.17 3.85434
SPDR Portfolio Europe ETF 0.00943 8.94 3.66537
Dimensional World ex U.S. Core Equity 2 ETF 0.00881 13.06 3.62488
Dimensional International Core Equity 2 ETF 0.00651 6.52 3.69996
SPDR Portfolio Developed World ex-US ETF 0.00638 5.29 3.28401
Dimensional International Core Equity Market ETF 0.00363 13.09 3.48343
SPDR Portfolio MSCI Global Stock Market ETF 0.00137 17.99 2.19607



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Mark Crossley CEO & Executive Director 2.34M
Mr. Ryan Preblick CFO & Executive Director 1.14M
Dr. Christian Heidbreder Chief Scientific Officer N/A
Mr. Jason Thompson Vice President of Investor Relations N/A
Ms. Cynthia Cetani Chief Integrity & Compliance Officer N/A
Mr. Jeffrey W. Burris Chief Legal Officer N/A 1972 (53 Jahr)
Mr. Jon Fogle Chief Human Resources Officer N/A
Mr. Richard Simkin Chief Commercial Officer N/A
Mr. Hillel West Chief Manufacturing & Supply Officer N/A
Mr. Vishal Kalia SVP of US Treatment Access, Support Programs & Business Insights and Chief Impact & Strategy Officer N/A

Adresse: United States, North Chesterfield. VA, 10710 Midlothian Turnpike - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.indivior.com